Innitius CerviSense platform is CE-marked and listed on the Voluson Solution Store by GE healthcare.

Public source

Publisher name

Public post

$28,998 vs $15,712. That's the cost difference between a pregnancy that ends in a cesarean section and another one that ends in a vaginal delivery. An 85% increase, acco…

Log in to read the full post

Company

Innitius

Quantifying cervical biomechanics for OBGYN

Industry
Medical Equipment Manufacturing
Location
Derio, ES
Company size
11–50 employees

About Innitius

Innitius is a medtech company focused on bringing a new diagnostic dimension to women’s health through cervical biomechanics. Our platform combines a CE-marked medical device with AI-based decision support to provide objective and quantitative assessment of cervical tissue, complementing existing ultrasound-based approaches. Designed to complement ultrasound, the technology captures biomechanical changes that are not visible through imaging alone. The company works with a growing network of leading hospitals across Europe and is expanding its clinical programs through multicenter studies across different applications in OBGYN. Innitius is advancing clinical validation while progressively scaling its presence in clinical practice.

See more

Latest activity

3 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.